AngioDynamics to Report Fiscal 2025 First Quarter Financial Results on October 3, 2024
AngioDynamics (NASDAQ: ANGO), a medical technology company specializing in vascular health and cancer treatment, has announced its plans to release fiscal 2025 first quarter financial results on October 3, 2024, before the market opens. The company will host a conference call at 8:00 am ET on the same day to discuss the results. Investors can participate by dialing 1-877-407-0784 (domestic) or +1-201-689-8560 (international). A webcast will be available on the company's website, and a recording of the call can be accessed until October 10, 2024, using the passcode 13748896.
AngioDynamics (NASDAQ: ANGO), un'azienda di tecnologia medica specializzata nella salute vascolare e nel trattamento del cancro, ha annunciato i suoi piani per rilasciare i risultati finanziari del primo trimestre dell'esercizio 2025 il 3 ottobre 2024, prima dell'apertura del mercato. L'azienda ospiterà una telefonata di conferenza alle 8:00 ora ET lo stesso giorno per discutere i risultati. Gli investitori possono partecipare chiamando il 1-877-407-0784 (nazionale) o il +1-201-689-8560 (internazionale). Una webconferenza sarà disponibile sul sito web dell'azienda, e una registrazione della chiamata potrà essere accessibile fino al 10 ottobre 2024, utilizzando il codice di accesso 13748896.
AngioDynamics (NASDAQ: ANGO), una empresa de tecnología médica especializada en la salud vascular y el tratamiento del cáncer, ha anunciado sus planes para publicar los resultados financieros del primer trimestre del ejercicio 2025 el 3 de octubre de 2024, antes de la apertura del mercado. La empresa llevará a cabo una llamada de conferencia a las 8:00 am ET ese mismo día para discutir los resultados. Los inversores pueden participar llamando al 1-877-407-0784 (nacional) o al +1-201-689-8560 (internacional). Se dispondrá de una transmisión web en el sitio web de la empresa, y una grabación de la llamada estará accesible hasta el 10 de octubre de 2024, utilizando la contraseña 13748896.
AngioDynamics (NASDAQ: ANGO)는 혈관 건강 및 암 치료를 전문으로 하는 의료 기술 회사로, 2025 회계연도 1분기 재무 결과를 2024년 10월 3일, 시장 개장 전에 발표할 계획이라고 발표했습니다. 회사는 같은 날 오전 8시 ET에 결과를 논의하기 위한 전화 회의를 주최합니다. 투자자들은 1-877-407-0784 (국내) 또는 +1-201-689-8560 (국제)로 전화하여 참여할 수 있습니다. 회사 웹사이트에서 웹캐스트를 제공하며, 호출 기록은 2024년 10월 10일까지 패스코드 13748896를 사용하여 접근할 수 있습니다.
AngioDynamics (NASDAQ: ANGO), une entreprise de technologie médicale spécialisée dans la santé vasculaire et le traitement du cancer, a annoncé son intention de publier les résultats financiers du premier trimestre de l'exercice 2025 le 3 octobre 2024, avant l'ouverture du marché. L'entreprise tiendra une conférence téléphonique à 8h00 ET le même jour pour discuter des résultats. Les investisseurs peuvent participer en composant le 1-877-407-0784 (national) ou le +1-201-689-8560 (international). Un webinaire sera disponible sur le site web de l'entreprise, et un enregistrement de l'appel sera accessible jusqu'au 10 octobre 2024, en utilisant le code d'accès 13748896.
AngioDynamics (NASDAQ: ANGO), ein Medizintechnikunternehmen, das auf vaskuläre Gesundheit und Krebsbehandlung spezialisiert ist, hat seine Pläne angekündigt, die finanziellen Ergebnisse des ersten Quartals des Geschäftsjahres 2025 am 3. Oktober 2024, vor Markteröffnung zu veröffentlichen. Das Unternehmen wird am selben Tag um 8:00 Uhr ET eine Telefonkonferenz abhalten, um die Ergebnisse zu besprechen. Investoren können teilnehmen, indem sie 1-877-407-0784 (national) oder +1-201-689-8560 (international) anrufen. Ein Webcast wird auf der Unternehmenswebsite verfügbar sein, und eine Aufzeichnung des Anrufs ist bis zum 10. Oktober 2024 mit dem Zugangscode 13748896 zugänglich.
- None.
- None.
To participate in the conference call, dial 1-877-407-0784 (domestic) or +1-201-689-8560 (international).
This conference call will also be webcast and can be accessed from the “Investors” section of the AngioDynamics website at www.angiodynamics.com. The webcast replay of the call will be available at the same site approximately one hour after the end of the call.
A recording of the call will also be available, until Thursday, October 10, 2024 at 11:59 pm ET. To hear this recording, dial 1-844-512-2921 (domestic) or +1-412-317-6671 (international) and enter the passcode 13748896.
About AngioDynamics, Inc.
AngioDynamics is a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life.
The Company’s innovative technologies and devices are chosen by talented physicians in fast-growing healthcare markets to treat unmet patient needs. For more information, visit www.angiodynamics.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240919022291/en/
Investors:
AngioDynamics, Inc.
Stephen Trowbridge, Executive Vice President & CFO
(518) 795-1408
Source: AngioDynamics, Inc.
FAQ
When will AngioDynamics (ANGO) report its fiscal 2025 Q1 financial results?
How can investors participate in AngioDynamics' (ANGO) fiscal 2025 Q1 earnings call?
Where can I find the webcast of AngioDynamics' (ANGO) fiscal 2025 Q1 earnings call?
Until when will the recording of AngioDynamics' (ANGO) fiscal 2025 Q1 earnings call be available?
